Axonics, Inc.
AXNXDelisted Nov 15, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001603756
Axonics, Inc. was delisted on Nov 15, 2024; its insiders filed their last Form 4 on Nov 15, 2024; 233 institutions reported holding it in 13F filings for Q3 2024, worth $3.54B in total; Soros Fund Management was the only superinvestor holding it.
Q4 2024 vs. Q3 2024
How the institutions holding Axonics, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 233 | 4 | 2 | −227 |
| Shares | 50.8M | 117.3K | 225.0K | −50.5M (−99.6%) |
| Value | $3.54B | $8.16M | $15.5M | −$3.51B (−99.6%) |
4 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (2)
Institutions that held Axonics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Taconic Capital Advisors LP | 225,000 | $15.5M | 1.21% |
| IFP Advisors, Inc | 1 | $71 | 0.00% |
Sold out (229)
Institutions that held Axonics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
Showing the largest 100 of 229 by value.
Not filed for Q4 2024 yet (4)
Institutions that held Axonics, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Eisler Capital (UK) Ltd. | 98,470 | $6.85M |
| Crystalline Management Inc. | 10,000 | $696.0K |
| Fort Pitt Capital Group, LLC | 5,000 | $348.0K |
| Verdad Advisers, LP | 3,842 | $267.4K |